navtemadlin (KRT-232)
Showing 1 - 25 of 47
Endometrial Cancer Trial (Navtemadlin, Navtemadlin Placebo)
Not yet recruiting
- Endometrial Cancer
- Navtemadlin
- Navtemadlin Placebo
- (no location specified)
Mar 21, 2023
Non Small Cell Lung Cancer Trial (Navtemadlin, Navtemadlin Placebo, Pembrolizumab)
Not yet recruiting
- Non Small Cell Lung Cancer
- Navtemadlin
- +2 more
- (no location specified)
Jan 27, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States
Suspended
- Acute Myeloid Leukemia
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- Cytarabine
- +2 more
-
Los Angeles, California
- +5 more
Dec 10, 2022
Resectable Soft Tissue Sarcoma, Soft Tissue Sarcoma Trial in United States (Navtemadlin, Radiation Therapy)
Recruiting
- Resectable Soft Tissue Sarcoma
- Soft Tissue Sarcoma
- Navtemadlin
- Radiation Therapy
-
Goodyear, Arizona
- +52 more
Jul 21, 2022
Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (KRT-232, acalabrutinib)
Recruiting
- Diffuse Large B Cell Lymphoma
- +2 more
-
Goshen, Indiana
- +44 more
Aug 3, 2022
Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in
Recruiting
- Primary Myelofibrosis (PMF)
- +2 more
- KRT-232
- Best Available Therapy (BAT)
-
Birmingham, Alabama
- +155 more
Aug 12, 2022
Proenkephalin A and Kidney Replacement Therapy
Suspended
- Acute Kidney Injury
- None planned
-
Gießen, Hessen, GermanyUniversity Hospital Gießen and Marburg
Jan 23, 2023
Acute Side Effects In Stage III NSCLC With Definitive CRT
Completed
- Non-small Cell Lung Cancer Stage III
-
Ankara, TurkeyAnkara University Medicine School Radiation Oncology
Aug 22, 2023
Acute Kidney Injury in Coronavirus Disease-19 Patients Admitted
Active, not recruiting
- Critical Illness
- +2 more
- Observational study exploring the epidemiology and outcomes of AKI in critical COVID-19 patients admitted to the ICU
-
Antwerp, Belgium
- +8 more
Jan 21, 2022
ICU Patients With Acute Kidney Injury
Recruiting
- Delirium
- +5 more
- Cerebral oxygenation
-
Kingston, Ontario, CanadaKingston Health Sciences Centre
Apr 18, 2022
Covid19 Trial in Tbilisi (ADAPT-232 oral solution, Placebo oral solution)
Completed
- Covid19
- ADAPT-232 oral solution
- Placebo oral solution
-
Tbilisi, GeorgiaNational Family Medicine Training Centre,
Dec 27, 2021
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in France, Netherlands, United States (AMG 232)
Completed
- Advanced Malignancy
- +7 more
- AMG 232
-
Santa Monica, California
- +13 more
Aug 30, 2021
GDM, Gestational Diabetes, Nutritional and Metabolic Diseases Trial in Herlev (Dietary treatment)
Not yet recruiting
- GDM
- +4 more
- Dietary treatment
-
Herlev, DenmarkSteno Diabetes Center Copenhagen
Nov 8, 2023
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Australia, United States (AMG 232, Trametinib, Dabrafenib)
Completed
- Advanced Malignancy
- +6 more
- AMG 232
- +2 more
-
Los Angeles, California
- +6 more
Mar 24, 2021
Atrial Fibrillation, Heart Diseases Trial in Moscow (Thoracoscopic surgical ablation)
Active, not recruiting
- Atrial Fibrillation
- Heart Diseases
- Thoracoscopic surgical ablation
-
Moscow, Russian Federation
- +1 more
Jan 24, 2023
Pain Trial in Belgium, Denmark, United States (bupivacaine liposome injectable suspension, Placebo)
Completed
- Pain
- bupivacaine liposome injectable suspension
- Placebo
-
Mobile, Alabama
- +16 more
Nov 6, 2020
Prostate Adenocarcinoma Trial in Navi-Mumbai (Moderate Hypo-fractionation, Extreme Hypo-fractionation)
Recruiting
- Prostate Adenocarcinoma
- Moderate Hypo-fractionation
- Extreme Hypo-fractionation
-
Navi-Mumbai, Maharashtra, IndiaDr Vedang Murthy
Mar 27, 2021